Estrogens inhibit copper and cell-mediated modification of low density lipoprotein

Atherosclerosis

Volumn 89, Issue 2-3, 1991, Pages 175-182

  Mazière, Cécile ^a   Auclair, Martine ^a   Ronveaux, Marie France ^a   Salmon, Suzanne ^a,b   Santus, René ^b   Maziere, Jean Claude ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Endothelial cells; Estrogens; LDL oxidation; Macrophages

Indexed keywords

COPPER; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; ENDOTHELIUM; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0025743026     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(91)90058-B     Document Type: Article

References (39)

1. The role of the monocyte in atherosclerosis; I. transition of blood-born monocytes into foam cells in fatty lesions
2. Characterization of lipid-laden aortic cells from cholesterol fed rabbits. IV Investigation of macrophage-like properties of aortic cell populations
3. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by the receptor for acetylated low density lipoproteins
4. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
5. Monocytes and neutrophils oxidize low density lipoproteins making it cytotoxic
6. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor
7. Decrease in reactive amino groups during oxidation or endothelial modification of LDL. Correlation with changes in receptor-mediated catabolism
8. Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products
9. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
10. Toxicity of oxidized low density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle
11. Enhanced macrophage degradation of biologically modified low density lipoprotein
12. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis
13. Role of oxidatively modified LDL in atherosclerosis
14. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
15. Low density lipoprotein undergoes oxidative modification in vivo
16. Characterization of two lipoproteins containing apolipoproteins B and E from lesion-free human aortic intima
17. Probucol inhibits oxidative modification of low density lipoprotein
18. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
19. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hype rcholesterolemia
20. Atherosclerotic risk factors. Are there ten or is there only one?
21. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit
22. Effect of 17/3-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
23. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
24. The metabolism of very low density lipoproteins. Preliminary in vivo and in vitro observations
25. Establishment and characterization of a human histiocytic lymphoma cell line
26. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
27. Lipid peroxides and human diseases
28. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia
29. Inhibitory effect of female hormones on lipid peroxidation
30. Estrogens as natural antioxidants of membrane phospholipid peroxidation
31. 17beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages
32. Superoxide initiates oxidation of low density lipoprotein by human monocytes
33. Oxidative modification of low density lipoprotein by activated human monocytes and the cell line U937 and HL60
34. Superoxide anion participation in human monocytemediated oxidation of low density lipoprotein and conversion of low density lipoprotein to a cytotoxin
35. The action of defined oxygen-centered free radicals on human low density lipoprotein
36. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein
37. The measurement of free radical reactions in humans. Some thoughts for future experimentation
38. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein
39. Multiple receptors for low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins